# BIOXCEL THERAPEUTICS INC (BTAI)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BTAI/

- Reporting holders: 1
- Reported value: $1
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1 | 25 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $1 |
| Q2 2026 | 48 | $9.0M |
| Q1 2026 | 39 | $7.3M |
| Q4 2025 | 41 | $5.7M |
| Q3 2025 | 35 | $6.1M |
| Q2 2025 | 35 | $1.2M |
| Q1 2025 | 31 | $791.2K |
| Q4 2024 | 50 | $3.3M |
| Q3 2024 | 49 | $1.9M |
| Q2 2024 | 75 | $13.0M |
| Q1 2024 | 73 | $28.5M |
| Q4 2023 | 76 | $30.5M |